miR-708-5p deficiency involves the degeneration of mandibular condylar chondrocytes via the TLR4/NF-κB pathway

Lingfeng Xu1, Yuejiao Zhang2, Jia Yu1

  • 1Department of Oral Anatomy and Physiology and TMD, College of Stomatology, the Fourth Military Medical University. Xi'an, China.

PubMed
Abstract

Insights

Degenerative shear stress induces senescence in temporomandibular joint cartilage cells, linked to age-related miR-708-5p decline. Restoring miR-708-5p levels offers a potential osteoarthritis treatment.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Osteoarthritis research

Background:

  • Aging and abnormal biomechanics are key osteoarthritis (OA) risk factors.
  • Cellular senescence characterizes aged cartilage, while cartilage degeneration marks osteoarthritic joints.
  • Temporomandibular joint (TMJ) cartilage exhibits zonal arrangement with deep zone cells differentiating from superficial zone cells (SZCs).

Purpose of the Study:

  • To investigate if degenerative shear stress (SS) triggers senescence in TMJ SZCs.
  • To identify the specific microRNA (miRNA) involved in this SS-induced senescence process.
  • To explore the potential of targeting this miRNA for OA treatment.

Main Methods:

  • TMJ SZCs from young rats were subjected to passaging or SS.
  • RNA sequencing identified miRNAs implicated in senescence and SS-induced degeneration.
  • Unilateral anterior crossbite (UAC) model in mice of different ages assessed OA development.
  • TMJ local injection of agomiR-708-5p evaluated its therapeutic effect.

Main Results:

  • Both replication and SS induced SZC senescence, with miR-708-5p identified as a key player.
  • Reduced miR-708-5p exacerbated senescence by activating the TLR4/NF-κB pathway.
  • miR-708-5p levels decreased with age in mouse TMJ cartilage.
  • Older mice showed more severe OA lesions after UAC; agomiR-708-5p injection ameliorated these lesions.

Conclusions:

  • Age-related deficiency in miR-708-5p contributes to mechanically induced osteoarthritis.
  • Intra-articular agomiR-708-5p administration presents a promising therapeutic strategy for OA.